Earnings Preview: Tango Therapeutics, Inc. (TNGX) Q2 Earnings Expected to Decline

The market expects Tango Therapeutics, Inc. (TNGX) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. Revenues are expected to be $7.39 million, down 49.4% from the year-ago quarter. Estimate revisions ahead of a company's ...